Table 3.
Resolve | Improve | Stable | Progress | ||
---|---|---|---|---|---|
Outcome | n (%) | n (%) | n (%) | n (%) | Total |
CN II | 5 (11.9) | 22 (52.4) | 7 (16.7) | 8 (19.0) | 42 |
CN III | 1 (6.7) | 9 (60.0) | 2 (13.3) | 3 (20.0) | 15 |
CN IV | 1 (33.3) | 2 (66.7) | 0 (0.0) | 0 (0.0) | 3 |
CN V | 3 (21.4) | 7 (50.0) | 3 (21.4) | 1 (7.1) | 14 |
CN VI | 5 (31.3) | 6 (37.5) | 2 (12.5) | 3 (18.8) | 16 |
CN VII | 7 (18.4) | 16 (42.1) | 5 (13.2) | 10 (26.3) | 38 |
CN VIII | 0 (0.0) | 4 (57.1) | 2 (28.6) | 1 (14.3) | 7 |
CN IX/X | 0 (0.0) | 1 (33.3) | 1 (33.3) | 1 (33.3) | 3 |
CN XII | 1 (33.3) | 1 (33.3) | 0 (0.0) | 1 (33.3) | 3 |
Extremity weakness |
2 (9.1) | 15 (68.2) | 2 (9.1) | 3 (13.6) | 22 |
Extremity numbness |
0 (0.0) | 11 (73.3) | 2 (13.3) | 2 (13.3) | 15 |
Headache | 9 (16.4) | 32 (58.2) | 8 (14.5) | 6 (10.9) | 55 |
Total | 34 (14.6) | 126 (54.1) | 34 (14.6) | 39 (16.7) | 233 |
Abbreviation: CN = cranial nerve.
Sufficient follow-up information was available for 149 patients with a total of 233 deficits.